251 related articles for article (PubMed ID: 10383692)
1. Malignant phyllodes tumours of the breast display increased stromal p53 protein expression.
Millar EK; Beretov J; Marr P; Sarris M; Clarke RA; Kearsley JH; Lee CS
Histopathology; 1999 Jun; 34(6):491-6. PubMed ID: 10383692
[TBL] [Abstract][Full Text] [Related]
2. Mammary fibroadenoma and some phyllodes tumour stroma are composed of CD34+ fibroblasts and factor XIIIa+ dendrophages.
Silverman JS; Tamsen A
Histopathology; 1996 Nov; 29(5):411-9. PubMed ID: 8951485
[TBL] [Abstract][Full Text] [Related]
3. Nuclear survivin expression in stromal cells of phyllodes tumors and fibroadenomas of the breast.
Hirano H; Matsushita K; Okimura A; Yoshida T; Kizaki T; Ito T
Anticancer Res; 2014 Mar; 34(3):1251-3. PubMed ID: 24596368
[TBL] [Abstract][Full Text] [Related]
4. p53 expression in phyllodes tumours is associated with histological features of malignancy but does not predict outcome.
Feakins RM; Mulcahy HE; Nickols CD; Wells CA
Histopathology; 1999 Aug; 35(2):162-9. PubMed ID: 10460662
[TBL] [Abstract][Full Text] [Related]
5. Estrogen receptor-beta is expressed in stromal cells of fibroadenoma and phyllodes tumors of the breast.
Sapino A; Bosco M; Cassoni P; Castellano I; Arisio R; Cserni G; Dei Tos AP; Fortunati N; Catalano MG; Bussolati G
Mod Pathol; 2006 Apr; 19(4):599-606. PubMed ID: 16554735
[TBL] [Abstract][Full Text] [Related]
6. Phyllodes tumors and fibroadenoma common beginning and different ending.
Oprić S; Oprić D; Gugić D; Granić M
Coll Antropol; 2012 Mar; 36(1):235-41. PubMed ID: 22816226
[TBL] [Abstract][Full Text] [Related]
7. ER, p53 and MIB-1 are significantly associated with malignant phyllodes tumor.
Munawer NH; Md Zin R; Md Ali SA; Muhammad R; Ali J; Das S
Biomed J; 2012; 35(6):486-92. PubMed ID: 23442362
[TBL] [Abstract][Full Text] [Related]
8. Phyllodes tumour of the breast: immunohistochemical study of 37 tumours using MIB1 antibody.
Kocová L; Skálová A; Fakan F; Rousarová M
Pathol Res Pract; 1998; 194(2):97-104. PubMed ID: 9584322
[TBL] [Abstract][Full Text] [Related]
9. Stromal CD10 expression in mammary fibroadenomas and phyllodes tumours.
Tse GM; Tsang AK; Putti TC; Scolyer RA; Lui PC; Law BK; Karim RZ; Lee CS
J Clin Pathol; 2005 Feb; 58(2):185-9. PubMed ID: 15677540
[TBL] [Abstract][Full Text] [Related]
10. Expression of CD34 and bcl-2 in phyllodes tumours, fibroadenomas and spindle cell lesions of the breast.
Moore T; Lee AH
Histopathology; 2001 Jan; 38(1):62-7. PubMed ID: 11135048
[TBL] [Abstract][Full Text] [Related]
11. Proliferating activity in the epithelial and stromal component of fibroadenomas and phyllodes tumours of the breast.
Barwijuk-Machała M; Reszeć J; Baltaziak M; Musiatowicz B; Cylwik J
Rocz Akad Med Bialymst; 2004; 49 Suppl 1():55-7. PubMed ID: 15638374
[TBL] [Abstract][Full Text] [Related]
12. Platelet-derived growth factor expression in phyllodes tumors and fibroadenomas of the breast.
Feakins RM; Wells CA; Young KA; Sheaff MT
Hum Pathol; 2000 Oct; 31(10):1214-22. PubMed ID: 11070114
[TBL] [Abstract][Full Text] [Related]
13. Beta-catenin abnormalities and associated insulin-like growth factor overexpression are important in phyllodes tumours and fibroadenomas of the breast.
Sawyer EJ; Hanby AM; Poulsom R; Jeffery R; Gillett CE; Ellis IO; Ellis P; Tomlinson IP
J Pathol; 2003 Aug; 200(5):627-32. PubMed ID: 12898599
[TBL] [Abstract][Full Text] [Related]
14. Cytological Criteria to Distinguish Phyllodes Tumour of the Breast from Fibroadenoma.
Maritz RM; Michelow PM
Acta Cytol; 2017; 61(6):418-424. PubMed ID: 28738381
[TBL] [Abstract][Full Text] [Related]
15. Expression of hypoxia-inducible factor 1 alpha and its downstream targets in fibroepithelial tumors of the breast.
Kuijper A; van der Groep P; van der Wall E; van Diest PJ
Breast Cancer Res; 2005; 7(5):R808-18. PubMed ID: 16168127
[TBL] [Abstract][Full Text] [Related]
16. Benign phyllodes tumour vs fibroadenoma: FNA cytological differentiation.
Veneti S; Manek S
Cytopathology; 2001 Oct; 12(5):321-8. PubMed ID: 11722512
[TBL] [Abstract][Full Text] [Related]
17. Endothelin-1 expression correlates with atypical histological features in mammary phyllodes tumours.
Tse GM; Chaiwun B; Lau KM; Scolyer R; Lee CS; Karim RZ; Putti TC; Law BK; Lui PC; Tan PH
J Clin Pathol; 2007 Sep; 60(9):1051-6. PubMed ID: 17158636
[TBL] [Abstract][Full Text] [Related]
18. DNA methylation profiling of phyllodes and fibroadenoma tumours of the breast.
Huang KT; Dobrovic A; Yan M; Karim RZ; Lee CS; Lakhani SR; Fox SB
Breast Cancer Res Treat; 2010 Nov; 124(2):555-65. PubMed ID: 20563638
[TBL] [Abstract][Full Text] [Related]
19. Expression of anaphase-promoting complex7 in fibroadenomas and phyllodes tumors of breast.
Kang Y; Kim JH; Lee TH; Kim TS; Jung WH; Chung HC; Park BW; Sheen SS; Han JH
Hum Pathol; 2009 Jan; 40(1):98-107. PubMed ID: 18789487
[TBL] [Abstract][Full Text] [Related]
20. The Wnt pathway, epithelial-stromal interactions, and malignant progression in phyllodes tumours.
Sawyer EJ; Hanby AM; Rowan AJ; Gillett CE; Thomas RE; Poulsom R; Lakhani SR; Ellis IO; Ellis P; Tomlinson IP
J Pathol; 2002 Apr; 196(4):437-44. PubMed ID: 11920740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
